Introduction
Amyotrophic lateral sclerosis (ALS) remains one of the most challenging neurodegenerative diseases to treat. Characterized by progressive degeneration of upper and lower motor neurons, ALS leads to worsening muscle weakness, respiratory failure, and ultimately death. Despite substantial advances in understanding its molecular pathology, effective disease-modifying therapies remain limited.
Among the emerging therapeutic strategies, modulation of the integrated stress response (ISR) has attracted considerable attention. The ISR is a cellular signaling pathway activated by various forms of stress, including protein misfolding, oxidative injury, and disturbances in cellular homeostasis. Although transient ISR activation can promote cellular survival, prolonged activation may suppress protein synthesis, impair neuronal function, and contribute to neurodegeneration.
Specialty calculators
For clinical reference; use professional judgment.
